We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
WEC Energy
WEC
$35.7B
| $15.5M | 0.04% |
312,383
-16,519
| -5% | -$864K |
|
377
Expeditors International
EXPD
$22B
| $15.4M | 0.04% |
319,025
+6,381
| +2% | +$294K |
|
378
Helmerich & Payne
HP
$3.45B
| $15.3M | 0.04% |
224,655
+17,996
| +9% | +$1.18M |
|
379
SL Green Realty
SLG
$3.76B
| $14.9M | 0.04% |
119,919
-10,378
| -8% | -$1.28M |
|
380
Best Buy
BBY
$18.2B
| $14.9M | 0.04% |
393,144
-4,655
| -1% | -$178K |
|
|
CTXS
381
DELISTED
Citrix Systems Inc
CTXS
| $14.8M | 0.04% |
290,608
-2,241
| -0.8% | -$110K |
|
382
Quest Diagnostics
DGX
$25.7B
| $14.7M | 0.04% |
190,955
-840
| -0.4% | -$60.2K |
|
383
Kimco Realty
KIM
$17.2B
| $14.6M | 0.04% |
545,541
-4,070
| -0.7% | -$109K |
|
|
VAR
384
DELISTED
Varian Medical Systems, Inc.
VAR
| $14.6M | 0.04% |
177,416
+2,932
| +2% | +$235K |
|
385
Newell Brands
NWL
$2.38B
| $14.6M | 0.04% |
374,053
-2,069
| -0.6% | -$79.7K |
|
386
Tesla
TSLA
$1.23T
| $14.6M | 0.04% |
1,160,625
+36,300
| +3% | +$490K |
|
387
Henry Schein
HSIC
$9.77B
| $14.6M | 0.04% |
266,659
-24,128
| -8% | -$1.32M |
|
388
NetApp
NTAP
$35B
| $14.6M | 0.04% |
411,718
-3,889
| -0.9% | -$149K |
|
389
Wabtec
WAB
$49.1B
| $14.6M | 0.04% |
153,619
+13,488
| +10% | +$1.22M |
|
390
Ball Corp
BALL
$17.3B
| $14.5M | 0.04% |
411,462
-4,440
| -1% | -$154K |
|
391
Xerox
XRX
$387M
| $14.5M | 0.04% |
428,488
-8,432
| -2% | -$298K |
|
392
Mettler-Toledo International
MTD
$28.6B
| $14.5M | 0.04% |
44,113
+3,479
| +9% | +$1.08M |
|
393
Wynn Resorts
WYNN
$10.3B
| $14.5M | 0.04% |
114,966
+988
| +0.9% | +$141K |
|
394
Lam Research
LRCX
$367B
| $14.4M | 0.04% |
2,056,080
-8,590
| -0.4% | -$67.9K |
|
395
NVIDIA
NVDA
$4.86T
| $14.4M | 0.04% |
27,590,000
-413,360
| -1% | -$220K |
|
396
Eastman Chemical
EMN
$8B
| $14.4M | 0.04% |
207,889
+371
| +0.2% | +$26.8K |
|
397
Newmont
NEM
$98.7B
| $14.4M | 0.04% |
661,194
+15,950
| +2% | +$373K |
|
398
Mohawk Industries
MHK
$7.5B
| $14.3M | 0.04% |
76,769
-898
| -1% | -$155K |
|
399
Republic Services
RSG
$64.8B
| $14.2M | 0.04% |
349,588
-2,670
| -0.8% | -$109K |
|
400
Tyson Foods
TSN
$20.4B
| $14.2M | 0.04% |
369,529
-840
| -0.2% | -$33.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.